Sunday, March 16.

After delays, Teva wins approval from U.S. for migraine treatment

.com/blogger_img_proxy/
Beleaguered Israeli drug company banking on Ajovy to boost sales, profits and offset the decline of its Copaxone MS treatment
Read More

No comments